Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ferguson

Showing results (261-270 of 739) with videos related to

Pageof 74
Sort By:
Brain : a Journal of Neurology|June 1, 1996
Focal upper limb demyelinating neuropathyP K Thomas, D Claus, A Jaspert, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Functional characterization of odorant receptors in the ponerine ant, <i>Harpegnathos saltator</i>Jesse D Slone, Gregory M Pask, Stephen T Ferguson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2021
Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World DataMartin Anderson, Kathryn Collison, M Bradley Drummond, et al.
The Lancet. Respiratory Medicine|November 13, 2018
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trialWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2021
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatmentWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.
Inhalation Toxicology|May 14, 2010
Aged particles derived from emissions of coal-fired power plants: the TERESA field resultsChoong-Min Kang, Tarun Gupta, Pablo A Ruiz, et al.
Human & Experimental Toxicology|March 1, 1997
Covert poisoning with difenacoum: clinical and toxicological observationsP T McCarthy, A D Cox, D J Harrington, et al.
Respiratory Research|June 2, 2011
Health status in the TORCH study of COPD: treatment efficacy and other determinants of changePaul W Jones, Julie A Anderson, Peter Ma Calverley, et al.
Analytical Chemistry|July 19, 2017
Hadamard-Transform Fluorescence Excitation-Emission-Matrix SpectroscopyN L P Andrews, T Ferguson, A M M Rangaswamy, et al.
The Lancet. Respiratory Medicine|May 27, 2017
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trialGary T Ferguson, J Mark FitzGerald, Eugene R Bleecker, et al.
Pageof 74

Showing results (261-270 of 739) with videos related to

Sort By:
Pageof 74
Brain : a Journal of Neurology|June 1, 1996
Focal upper limb demyelinating neuropathyP K Thomas, D Claus, A Jaspert, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Functional characterization of odorant receptors in the ponerine ant, <i>Harpegnathos saltator</i>Jesse D Slone, Gregory M Pask, Stephen T Ferguson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2021
Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World DataMartin Anderson, Kathryn Collison, M Bradley Drummond, et al.
The Lancet. Respiratory Medicine|November 13, 2018
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trialWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2021
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatmentWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.
Inhalation Toxicology|May 14, 2010
Aged particles derived from emissions of coal-fired power plants: the TERESA field resultsChoong-Min Kang, Tarun Gupta, Pablo A Ruiz, et al.
Human & Experimental Toxicology|March 1, 1997
Covert poisoning with difenacoum: clinical and toxicological observationsP T McCarthy, A D Cox, D J Harrington, et al.
Respiratory Research|June 2, 2011
Health status in the TORCH study of COPD: treatment efficacy and other determinants of changePaul W Jones, Julie A Anderson, Peter Ma Calverley, et al.
Analytical Chemistry|July 19, 2017
Hadamard-Transform Fluorescence Excitation-Emission-Matrix SpectroscopyN L P Andrews, T Ferguson, A M M Rangaswamy, et al.
The Lancet. Respiratory Medicine|May 27, 2017
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trialGary T Ferguson, J Mark FitzGerald, Eugene R Bleecker, et al.
Pageof 74